Weiss Multi-Strategy Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,126
Closed -$10.6M 272
2023
Q4
$10.6M Buy
18,126
+1,471
+9% +$859K 0.25% 94
2023
Q3
$8.95M Sell
16,655
-15,608
-48% -$8.04M 0.21% 133
2023
Q2
$15.1M Sell
32,263
-18,707
-37% -$7.85M 0.31% 85
2023
Q1
$17.5M Buy
50,970
+42,599
+509% +$14.4M 0.41% 66
2022
Q4
$3.06M Sell
8,371
-33,139
-80% -$11.7M 0.09% 306
2022
Q3
$13.4M Sell
41,510
-4,888
-11% -$1.55M 0.36% 84
2022
Q2
$15M Buy
46,398
+13,548
+41% +$4.07M 0.45% 45
2022
Q1
$9.41M Buy
32,850
+515
+2% +$133K 0.22% 161
2021
Q4
$8.93M Buy
32,335
+7,335
+29% +$1.86M 0.2% 150
2021
Q3
$5.78M Buy
25,000
+5,000
+25% +$1.23M 0.12% 232
2021
Q2
$4.59M Buy
20,000
+4,966
+33% +$998K 0.1% 278
2021
Q1
$2.81M Buy
15,034
+5,309
+55% +$1.04M 0.06% 357
2020
Q4
$1.64M Buy
9,725
+8,025
+472% +$1.2M 0.03% 444
2020
Q3
$252K Buy
+1,700
New +$263K 0.01% 520
2017
Q2
Sell
-6,126
Closed -$515K 591
2017
Q1
$515K Sell
6,126
-12
-0.2% -$961 0.02% 444
2016
Q4
$451K Sell
6,138
-4,973
-45% -$370K 0.02% 335
2016
Q3
$892K Buy
11,111
+16
+0.1% +$1.28K 0.06% 302
2016
Q2
$874K Sell
11,095
-1,590
-13% -$120K 0.07% 276
2016
Q1
$913K Buy
+12,685
New +$960K 0.04% 345
2014
Q2
Sell
-6,890
Closed -$406K 836
2014
Q1
$406K Buy
6,890
+2,470
+56% +$138K 0.01% 752
2013
Q4
$225K Sell
4,420
-25,740
-85% -$1.29M ﹤0.01% 880
2013
Q3
$1.52M Buy
+30,160
New +$1.58M 0.03% 371

Other funds holding LLY

Weiss Multi-Strategy Advisers's LLY Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 18,126 shares — an estimated $10.6M sold.

Weiss Multi-Strategy Advisers first reported a position in LLY in Q3 2013 and held it in 22 quarters. The position peaked at $17.5M in Q1 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 18,126 Eli Lilly shares in Q1 2024, an estimated $10.6M.
  • Weiss Multi-Strategy Advisers first reported a position in Eli Lilly in Q3 2013 and held it in 22 quarters.
  • Weiss Multi-Strategy Advisers's Eli Lilly position peaked at $17.5M in Q1 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.